Skip to main content
. Author manuscript; available in PMC: 2025 Nov 1.
Published in final edited form as: J Card Fail. 2024 Apr 13;30(11):1462–1468. doi: 10.1016/j.cardfail.2024.03.012

Table 1.

Baseline characteristics stratified by sarcopenia as defined by pectoralis muscle index (pectoralis muscle area indexed to height) at lowest sex-specific tertile

Variable All (n=169) Sarcopenia (n=55) No sarcopenia (n=114) p-value
Pectoralis muscle area index (cm2/m2) 6.2 (4.9, 7.6) 4.6 (3.9, 5.1) 6.9 (6.1–9.2)
Pectoralis muscle density (HU) 32.8 (26.8, 38.6) 30.7 (24.8, 34.0) 35.3 (24.8, 34.0)
Age 55.0 (46.0, 63.8) 60.0 (46.0–67.5) 54.0 (46.0–61.0) 0.011
Female sex (%) 49 (29.4) 17 (30.9) 33 (28.9) 0.935
Blood type (%) 0.558
A 65 (38.2) 23 (41.8) 42 (36.8)
AB 11 (6.5) 3 (5.5) 7 (6.1)
B 30 (17.6) 12 (21.8) 18 (15.8)
O 64 (37.6) 17 (30.9) 47 (41.2)
Race/ethnicity 0.025
Black 42 (24.7) 8 (14.5) 34 (29.8)
White 87 (51.2) 36 (65.5) 51 (44.7)
Hispanic 27 (15.9) 5 (9.1) 21 (18.4)
Other 14 (8.2) 6 (10.9) 8 (7.0)
Heart failure etiology (%) 0.654
Ischemic 30 (17.6) 10 (18.2) 20 (17.5)
Non-ischemic 106 (62.4) 34 (61.8) 71 (62.3)
Congenital 11 (6.5) 2 (3.6) 9 (7.9)
Restrictive/infiltrative 10 (5.9) 5 (9.1) 5 (4.4)
Retransplant 13 (7.6) 4 (7.3) 9 (7.9)
BMI at transplant 25.9 (22.4, 30.5) 23.8 (21.3, 26.1) 27.5 (23.6, 31.2) <0.001
ICD prior to transplant (%) 105 (61.8) 35 (63.6) 69 (60.5) 0.825
Diabetes (%) 35 (20.6) 13 (23.6) 22 (19.3) 0.653
Prior stroke (%) 25 (14.7) 6 (10.9) 19 (16.7) 0.449
Renal dysfunction (EGFR<60) (%) 69 (40.6) 26 (47.3) 43 (37.7) 0.309
LVAD at transplant (%) 22 (12.9) 7 (12.7) 15 (13.2) 1.000
ECMO at transplant (%) 25 (14.7) 8 (14.5) 17 (14.9) 1.000
IABP at transplant (%) 60 (35.3) 22 (40.0) 38 (33.3) 0.498
Status at transplant (%) 0.630
1 24 (14.1) 7 (12.7) 17 (14.9)
2 94 (53.3) 33 (60.0) 61 (53.5)
3 33 (19.4) 9 (16.4) 23 (20.2)
4 16 (9.4) 4 (7.3) 12 (10.5)
5 2 (1.2) 1 (1.8) 1 (0.9)
6 1 (0.6) 1 (1.8) 0 (0.0)
Serum albumin (g/dl) 4.0 (3.5, 4.4) 4.0 (3.5, 4.4) 4.0 (3.7, 4.4) 0.579